Following a recent cybersecurity executive order, agencies face new requirements to ensure they are protected against the evolving cyber threat landscape. Kevin Fu, acting director of medical device cybersecurity at FDA's Center for Devices and Radiological Health, dives into how the agency is developing new guidance and playbooks to guide organizations through medical device development and emphasizes the importance of threat modeling and software bills of material to combat potential vulnerabilities.